S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

GER Goldman Sachs MLP Energy Renaissance Fund

15.67

0.00 (0.00%)

May 08 2024 - Closed

Delayed by 15 minutes

Form N-PX - Annual Report of proxy voting record of management investment companies

Goldman Sachs MLP Energy... (NYSE:GER)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Goldman Sachs MLP Energy... Charts.

Goldman Sachs MLP Energy... (NYSE:GER)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Goldman Sachs MLP Energy... Charts.

Goldman Sachs MLP Energy Renaissance Fund News

Form 40-17G - Fidelity Bond [Rule 17G-1(g)]
Monday 25 March 2024 (1 month ago) • Edgar (US Regulatory)

Form N-8F ORDR - N-8F Order
Monday 27 November 2023 (5 months ago) • Edgar (US Regulatory)

Form N-8F - Application for Deregistration
Friday 22 September 2023 (8 months ago) • Edgar (US Regulatory)

Form N-PX - Annual Report of proxy voting record of management investment companies
Wednesday 30 August 2023 (8 months ago) • Edgar (US Regulatory)

Form N-CSRS - Certified Shareholder Report, Semi-Annual
Monday 24 July 2023 (10 months ago) • Edgar (US Regulatory)

Goldman Sachs Asset Management Announces Liquidation Details for Goldman Sachs MLP and Energy Renaissance Fund
Friday 16 June 2023 (11 months ago) • Business Wire

Goldman Sachs Asset Management Announces Liquidation of Goldman Sachs MLP and Energy Renaissance Fund
Wednesday 7 June 2023 (11 months ago) • Business Wire

Goldman Sachs Asset Management Announces Quarterly Distribution of $0.240 Per Share
Friday 12 May 2023 (12 months ago) • Business Wire

More Goldman Sachs MLP Energy Renaissance Fund News Articles

ProText Mobility (PK)

Emergent Health (PK)

Music Licensing (PK)

GNCC Capital (CE)

NaturalShrimp (QB)

Ecare Solutions (PK)

Ronn Motor (PK)

Brookmount Explorations (PK)

Clean Vision (QB)

Yuenglings Ice Cream (PK)

Innovation Pharmaceuticals (CE)

Globestar Therapeutics (PK)

Elite Pharmaceuticals (QB)

Anavex Life Sciences

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions